Literature DB >> 26094532

Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.

Andrzej Prystupa1, Anna Boguszewska-Czubara2, Agnieszka Bojarska-Junak3, Anna Toruń-Jurkowska4, Jacek Roliński3, Wociech Załuska5.   

Abstract

In alcoholic liver cirrhosis, normal liver cells are replaced by scar tissue (fibrosis). Liver fibrosis is a dynamic process in which activated hepatic stellate cells are involved in the synthesis of matrix proteins and the regulation of matrix degeneration. The aim of the presented study was to assess the usefulness of MMP-2, MMP-8 and MMP-9 as diagnostic markers of alcoholic liver disease. Sixty patients with alcoholic liver cirrhosis were randomly enrolled during hospitalization in departments of hospitals from the Lublin Region in eastern Poland. The stage of cirrhosis was estimated according to Child-Turcotte-Pugh criteria (Child-Pugh score) as P- Ch A, P-Ch B, P-Ch C. The control group consisted of 10 healthy persons without liver disease, who did not drink alcohol. Additionally, a group of alcoholics without liver cirrhosis was included in the study. Blood sample were obtained, and after centrifuge, serum was collected for further analysis. The activity of MMP-2, MMP-8 and MMP-9 in the blood plasma of the patients and the control group were measured by using the sandwich enzyme immunoassay technique with commercially available quantitative ELISA test kits. Activity of MMP-2, MMP-8 and MMP-9 in patients with liver cirrhosis were increased gradually according to Child-Pugh stages. The activity of MMP-2, MMP-8, MMP-9 were the highest in patients with liver cirrhosis stage C. MMP-2, MMP-8, MMP-9 concentrations in the people with liver cirrhosis (stage C) were significantly increased compared to controls. A significant difference were observed between activity MMP-2 in control group, alcoholics without liver cirrhosis, and those with liver cirrhosis (stages A, B, C according Child-Pugh score). MMP-2, MMP-8 and MMP-9 may be markers of alcoholic liver cirrhosis in the alcoholics. Elevated levels of MMP-2, MMP-8 and MMP-9 in the alcoholic patients indicated that cirrhosis has developed. The most sensitive is MMP-2, because the activity of this parameter is increased in all liver cirrhosis stages. MMP-8 and MMP-9 activity were significantly elevated only in serum patients with advanced liver cirrhosis, compared to controls.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26094532     DOI: 10.5604/12321966.1152088

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  9 in total

1.  Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents-A Preliminary Study.

Authors:  Katarzyna Zdanowicz; Monika Kowalczuk-Kryston; Witold Olanski; Irena Werpachowska; Wlodzimierz Mielech; Dariusz Marek Lebensztejn
Journal:  Biomolecules       Date:  2022-05-16

Review 2.  Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis.

Authors:  Chien-Yu Lin; Pratik Adhikary; Kun Cheng
Journal:  Adv Drug Deliv Rev       Date:  2021-04-20       Impact factor: 17.873

Review 3.  Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives.

Authors:  Ryota Masuzaki; Tatsuo Kanda; Reina Sasaki; Naoki Matsumoto; Masahiro Ogawa; Shunichi Matsuoka; Seth J Karp; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

4.  Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice.

Authors:  Ying Wu; Zhen Li; Ai-Yuan Xiu; Dong-Xiao Meng; Si-Ning Wang; Chun-Qing Zhang
Journal:  Drug Des Devel Ther       Date:  2019-08-01       Impact factor: 4.162

5.  Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells Through the Inhibition of the TGF-β1-Induced SMAD2/3 Signaling Pathway.

Authors:  Mattareeyapar Phaosri; Salinee Jantrapirom; Mingkwan Na Takuathung; Noppamas Soonthornchareonnon; Seewaboon Sireeratawong; Pensiri Buacheen; Pornsiri Pitchakarn; Wutigri Nimlamool; Saranyapin Potikanond
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

6.  Insights into the molecular mechanisms of Huangqi decoction on liver fibrosis via computational systems pharmacology approaches.

Authors:  Biting Wang; Zengrui Wu; Weihua Li; Guixia Liu; Yun Tang
Journal:  Chin Med       Date:  2021-07-23       Impact factor: 5.455

7.  Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis.

Authors:  Alicja Bauer; Andrzej Habior
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

8.  Up-regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation.

Authors:  Takahiro Tomiyama; Takuya Yamamoto; Shokichi Takahama; Takeo Toshima; Shinji Itoh; Noboru Harada; Mototsugu Shimokawa; Daisuke Okuzaki; Masaki Mori; Tomoharu Yoshizumi
Journal:  Hepatol Commun       Date:  2022-07-27

Review 9.  Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases.

Authors:  Eline Geervliet; Ruchi Bansal
Journal:  Cells       Date:  2020-05-13       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.